GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	7.36B +133.4%
Revenue (ttm)	3.73B +24.7%
Net Income	213.23M +22.6%
EPS	2.55 +22.6%
Shares Out	83.51M
PE Ratio	34.50
Forward PE	n/a
Dividend	1.00 (1.36%)
Ex-Dividend Date	Jan 12, 2026

Volume	35,955
Open	74.79
Previous Close	74.79
Day's Range	73.00 - 74.79
52-Week Range	40.56 - 81.50
Beta	0.80
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2025, GlaxoSmithKline S.A.E's revenue was 3.73 billion, an increase of 24.73% compared to the previous year's 2.99 billion. Earnings were 213.23 million, an increase of 22.56%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 15, 2026

Data Sources Report a data error